Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.17
Price to sales ratio
5.69

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3280
FHTX
Foghorn Therapeutics Inc. - Common Stock
5.44 USD-8.57%+7.72%+28.30%+33.33%319.40 M USD
3316
IRD
Opus Genetics, Inc. - Common Stock
3.81 USD-2.81%-7.30%-7.52%+2.42%310.12 M USD
3333
OABI
OmniAb, Inc. - Common Stock
2.11 USD-7.86%-12.45%-8.66%+1.93%305.89 M USD
3337
LCTX
Lineage Cell Therapeutics, Inc. Common Stock
1.22 USD-4.69%-8.96%-6.15%-28.95%304.14 M USD

Frequently asked questions about Editas Medicine, Inc. - Common Stock

What is the Editas Medicine, Inc. - Common Stock stock price today?

The current price of Editas Medicine, Inc. - Common Stock (EDIT) is 3.16. Over the past 24 hours, the stock has changed by -3.07%. Follow the EDIT chart for real-time price dynamics.

What is the stock ticker of Editas Medicine, Inc. - Common Stock?

Editas Medicine, Inc. - Common Stock trades under the ticker EDIT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Editas Medicine, Inc. - Common Stock stock going up?

EDIT has changed by -13.42% over the last week, +24.90% over the last month, and +9.72% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Editas Medicine, Inc. - Common Stock net income for the last quarter?

Editas Medicine, Inc. - Common Stock reported net income of -24.98 M for the last quarter. The previous quarter showed -5.62 M, which means net income changed by -344.52%.

How many employees does Editas Medicine, Inc. - Common Stock have?

As of the latest available data, Editas Medicine, Inc. - Common Stock has 87 employees. Workforce size can provide additional context about the company's scale and operations.

What is Editas Medicine, Inc. - Common Stock EBITDA?

Editas Medicine, Inc. - Common Stock EBITDA is -24.52 M, and its EBITDA margin is -866.13%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Editas Medicine, Inc. - Common Stock stock?

You can buy Editas Medicine, Inc. - Common Stock (EDIT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Editas Medicine, Inc. - Common Stock stock?

Investing in Editas Medicine, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EDIT chart and related analysis on metatrader.com as part of your research.

Editas Medicine, Inc. - Common Stock

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

News